NCT04810533View on ClinicalTrials.gov

The Absorption, Metabolism and Excretion of [14C]SH-1028 in Chinese Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

May 13, 2020

Primary Completion Date

March 5, 2021

Study Completion Date

March 5, 2021

Conditions
Healthy Male Volunteers
Interventions
DRUG

[14C] SH-1028

Volunteer will receive a single oral dose of 200 mg/88 uCi \[14C\]SH-1028 as a solution on Day 1

Trial Locations (1)

210029

Jiangsu Province Hospital Affiliated to Nanjing Madical University of Medicine, Nanjing

All Listed Sponsors
lead

Nanjing Sanhome Pharmaceutical, Co., Ltd.

INDUSTRY

NCT04810533 - The Absorption, Metabolism and Excretion of [14C]SH-1028 in Chinese Healthy Male Volunteers | Biotech Hunter | Biotech Hunter